Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 605

1.

Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.

Tükel R, Gürvit H, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Baran B, Kalem SA, Büyükgök D, Direskeneli GS.

Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):850-8. doi: 10.1002/ajmg.b.32092.

PMID:
22911909
2.

Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.

Hashim HM, Fawzy N, Fawzi MM, Karam RA.

J Psychiatr Res. 2012 Jun;46(6):762-6. doi: 10.1016/j.jpsychires.2012.03.007.

PMID:
22521161
3.

The relationship between the Met allele of the BDNF Val66Met polymorphism and impairments in decision making under ambiguity in patients with obsessive-compulsive disorder.

da Rocha FF, Malloy-Diniz L, Lage NV, Corrêa H.

Genes Brain Behav. 2011 Jul;10(5):523-9. doi: 10.1111/j.1601-183X.2011.00687.x.

4.

Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.

Vilkki J, Lappalainen J, Juvela S, Kanarek K, Hernesniemi JA, Siironen J.

Neurosurgery. 2008 Aug;63(2):198-203; discussion 203. doi: 10.1227/01.NEU.0000320382.21577.8E.

PMID:
18797348
5.

BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.

Wang Y, Zhang H, Li Y, Wang Z, Fan Q, Yu S, Lin Z, Xiao Z.

J Affect Disord. 2015 Nov 1;186:7-12. doi: 10.1016/j.jad.2015.07.023.

PMID:
26209750
7.

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P.

Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1050-62. doi: 10.1002/ajmg.b.30930.

PMID:
19219856
8.

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, Rabbitt P, Pendleton N, Horan M, Payton A.

Genes Brain Behav. 2008 Jun;7(4):411-7.

9.

Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.

Wang J, Zhang F, Zhu W, Liu Y, Zhou Z.

Acta Neuropsychiatr. 2015 Dec;27(6):327-35. doi: 10.1017/neu.2015.38.

PMID:
26503495
10.

Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.

Fullana MA, Alonso P, Gratacòs M, Jaurrieta N, Jiménez-Murcia S, Segalàs C, Real E, Estivill X, Menchón JM.

Eur Psychiatry. 2012 Jul;27(5):386-90. doi: 10.1016/j.eurpsy.2011.09.005.

PMID:
22153732
11.

BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder.

Hemmings SM, Lochner C, van der Merwe L, Cath DC, Seedat S, Stein DJ.

J Psychiatr Res. 2013 Dec;47(12):1857-63. doi: 10.1016/j.jpsychires.2013.08.012.

PMID:
24050777
12.

Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.

Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A, Frodl T.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jul;159B(5):537-48. doi: 10.1002/ajmg.b.32060.

PMID:
22585743
13.

BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.

Aas M, Haukvik UK, Djurovic S, Bergmann Ø, Athanasiu L, Tesli MS, Hellvin T, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, Melle I.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:181-8. doi: 10.1016/j.pnpbp.2013.07.008.

PMID:
23876786
14.

Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.

Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X.

Biol Psychiatry. 2008 Mar 15;63(6):619-28.

PMID:
17884018
15.

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

Frodl T, Schüle C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM.

Arch Gen Psychiatry. 2007 Apr;64(4):410-6.

PMID:
17404118
16.

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.

Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, Czerski PM, Hauser J.

Psychiatry Clin Neurosci. 2006 Feb;60(1):70-6.

17.

Do obsessive-compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population.

Liu S, Cui J, Niu Z, Yi M, Zhang X, Che F, Ma X.

World J Biol Psychiatry. 2015;16(8):602-9. doi: 10.3109/15622975.2015.1012226.

PMID:
25771937
18.

Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.

Koolschijn PC, van Haren NE, Bakker SC, Hoogendoorn ML, Hulshoff Pol HE, Kahn RS.

Hippocampus. 2010 Sep;20(9):1010-7. doi: 10.1002/hipo.20699.

PMID:
19714565
19.

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T.

Neurosci Lett. 2006 Jun 19;401(1-2):1-5.

PMID:
16533563
20.

The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.

Tükel R, Ozata B, Oztürk N, Ertekin BA, Ertekin E, Direskeneli GS.

J Clin Neurosci. 2014 May;21(5):790-3. doi: 10.1016/j.jocn.2013.07.037.

PMID:
24291483
Items per page

Supplemental Content

Support Center